Case Report: From misdiagnosis to successful treatment using mepolizumab in ANCA-negative severe EGPA-clinical lessons in eosinophil-targeted therapy. [PDF]
Li JZ, Guan SY, Wu QZ, Zheng JN.
europepmc +1 more source
High degree of remission in pediatric severe asthma patients treated with biologics in a real-world setting. [PDF]
Cerda Reyes S +2 more
europepmc +1 more source
Effect of Delayed Initiation of Mepolizumab on EXACTO Scale Scores, Clinical Remission SEPAR-REMAS Criteria, and Functional Outcomes in Uncontrolled Severe Asthma: A Real-World Study. [PDF]
León-Lloreda A +8 more
europepmc +1 more source
Biological treatments for asthma and chronic obstructive pulmonary disease. [PDF]
Tejwani V +4 more
europepmc +1 more source
Efficacy of Biologics in Patients with Moderate to Very Severe COPD: A Systematic Review. [PDF]
Brightling CE +12 more
europepmc +1 more source
Exploratory investigation of changes in blood transcriptome following mepolizumab treatment for asthma. [PDF]
Pitlick M +8 more
europepmc +1 more source
Tezepelumab in severe asthma with pulmonary mucus plugs and eosinophilic chronic rhinosinusitis after dupilumab intolerance and suboptimal mepolizumab response: A case report. [PDF]
Senoo S +11 more
europepmc +1 more source
Therapeutic Efficacy of Anti-Interleukin-5 Monoclonal Antibodies in Kimura Disease: A Systematic Review. [PDF]
Olizarowicz S +3 more
europepmc +1 more source
Biologic Switching in Patients with Severe Asthma: Effects on Exacerbations, Corticosteroid Use and Lung Function. [PDF]
Dindar Çelik F, Aksu K.
europepmc +1 more source

